Chris Adams of Andarix Pharmaceuticals
joined us for World Orphan Drug Congress USA 2015 to present about '
Tozaride: Targeted & Personalized Therapy for Small Cell Lung and Neuroendocrine Cancer'
Download his presentation to understand more about:
-
Receptor-targeted therapy
-
Tozaride Key Properties
-
Vixilide--Clinical Data
...and much more!
Get your copy here!
To find out more about
personalized therapy for small cell lung and neuroendocrine cancer
, attend
World Orphan Drug Congress USA 2016 April 20-22
in Washington, DC.